a double-blind crossover study was carried out in 24 patients with rheumatoid arthritis to investigate the relative efficacy of tolmetin ( 1600 mg/day ) and phenylbutazone ( 400 mg/day ) .
C0003873
rheumatoid
C0040377
tolmetin